Literature DB >> 2126377

Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis.

I Virgolini1, C Müller, P Fitscha, P Chiba, H Sinzinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2126377

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  6 in total

1.  Strategic targeting of atherosclerotic lesions.

Authors:  J Narula; R Virmani; A E Iskandrian
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 2.  Targeting the vulnerable plaque: the evolving role of nuclear imaging.

Authors:  John R Davies; James F Rudd; Tim D Fryer; Peter L Weissberg
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

3.  Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.

Authors:  I Carrió; P L Pieri; J Narula; L Prat; P Riva; L Pedrini; E Pretolani; G Caruso; G Sarti; M Estorch; L Berná; V Riambau; X Matías-Guiu; C Pak; C Ditlow; F Chen; B A Khaw
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 4.  Antibody imaging in the evaluation of cardiovascular diseases.

Authors:  B A Khaw; J Narula
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

5.  [PET/CT imaging of atherosclerotic blood vessel alterations].

Authors:  A Rominger; C Rist; K Nikolaou; M F Reiser; P Bartenstein; M Hacker; T Saam
Journal:  Radiologe       Date:  2010-04       Impact factor: 0.635

Review 6.  Radionuclide imaging: a molecular key to the atherosclerotic plaque.

Authors:  Harald F Langer; Roland Haubner; Bernd J Pichler; Meinrad Gawaz
Journal:  J Am Coll Cardiol       Date:  2008-07-01       Impact factor: 24.094

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.